{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:47:09Z","timestamp":1793170029115,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["ORF-2025-414"],"award-info":[{"award-number":["ORF-2025-414"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["ORF-2025-414"],"award-info":[{"award-number":["ORF-2025-414"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05497-y","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:32:16Z","timestamp":1771061536000},"page":"1789-1805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gomisin A and metformin co-treatment attenuates diabetic nephropathy and cardiovascular dysfunction by modulating the AGE\/RAGE pathway in a diabetic rat model"],"prefix":"10.1007","volume":"481","author":[{"given":"S. P. Ramya Ranjan","family":"Nayak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Pohokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Valan","family":"Arasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"lavenil","family":"Soundharrajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesu","family":"Arockiaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"5497_CR1","doi-asserted-by":"publisher","DOI":"10.48048\/tis.2023.6394","volume":"20","author":"RRNS Pushpa","year":"2023","unstructured":"Pushpa RRNS, Babulal KS, Kumaran R, Shoba G, Balakumaran MD (2023) In silico molecular interaction analysis and pharmacokinetic profiling of flavonoids from Catharanthus roseus (flower) against TXNIP protein. Trends Sci 20:6394","journal-title":"Trends Sci"},{"key":"5497_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","volume":"128","author":"K Ogurtsova","year":"2017","unstructured":"Ogurtsova K, Fernandes R, da JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH et al (2017) IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 128:40\u201350","journal-title":"Diabetes Res Clin Pract"},{"key":"5497_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2047487319878371","volume":"26","author":"E Dal Canto","year":"2019","unstructured":"Dal Canto E, Ceriello A, Ryd\u00e9n L, Ferrini M, Hansen TB, Schnell O et al (2019) Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol 26:25\u201332","journal-title":"Eur J Prev Cardiol"},{"key":"5497_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.18","volume":"1","author":"MC Thomas","year":"2015","unstructured":"Thomas MC, Brownlee M, Susztak K, Sharma K, Jandeleit-Dahm KAM, Zoungas S et al (2015) Diabetic kidney disease. Nat Rev Dis Primers 1:15018","journal-title":"Nat Rev Dis Primers"},{"key":"5497_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4239\/wjd.v1.i2.48","volume":"1","author":"PK Dabla","year":"2010","unstructured":"Dabla PK (2010) Renal function in diabetic nephropathy. World J Diabetes 1:48","journal-title":"World J Diabetes"},{"key":"5497_CR6","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/j.ajkd.2017.10.026","volume":"71","author":"K Umanath","year":"2018","unstructured":"Umanath K, Lewis JB (2018) Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis 71:884\u2013895","journal-title":"Am J Kidney Dis"},{"key":"5497_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011295","author":"S Raghavan","year":"2019","unstructured":"Raghavan S, Vassy JL, Ho Y, Song RJ, Gagnon DR, Cho K et al (2019) Diabetes mellitus\u2013related all-cause and cardiovascular mortality in a national cohort of adults. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.118.011295","journal-title":"J Am Heart Assoc"},{"key":"5497_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2020.11.003","volume":"47","author":"VH Schmitt","year":"2021","unstructured":"Schmitt VH, Hobohm L, M\u00fcnzel T, Wenzel P, Gori T, Keller K (2021) Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction. Diabetes Metab 47:101211","journal-title":"Diabetes Metab"},{"key":"5497_CR9","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1152\/physrev.00029.2022","volume":"103","author":"RL Chevalier","year":"2023","unstructured":"Chevalier RL (2023) Bioenergetics: the evolutionary basis of progressive kidney disease. Physiol Rev 103:2451\u20132506","journal-title":"Physiol Rev"},{"key":"5497_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/9781394205066.ch9","volume-title":"Care of Older People with Diabetes","author":"L Rodr\u00edguez-Ma\u00f1as","year":"2025","unstructured":"Rodr\u00edguez-Ma\u00f1as L, Sandoval\u2010Santoyo RE, Castro\u2010Rodr\u00edguez M, Subkhan A, Majid A, Ali A (2025) Macrovascular Complications. Care of Older People with Diabetes. Wiley, pp 81\u2013107"},{"key":"5497_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/9781119697473.ch46","volume-title":"Textbook of Diabetes","author":"JA \u00d8stergaard","year":"2024","unstructured":"\u00d8stergaard JA, Block TJ, Dahm S, Khan W, Jandeleit-Dahm KAM (2024) Pathogenesis of Macrovascular Complications in Diabetes. Textbook of Diabetes. Wiley, pp 679\u2013699"},{"key":"5497_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002146","volume":"9","author":"A Gonz\u00e1lez-P\u00e9rez","year":"2021","unstructured":"Gonz\u00e1lez-P\u00e9rez A, Saez M, Vizcaya D, Lind M, Garcia Rodriguez L (2021) Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK. BMJ Open Diabetes Res. Care 9:e002146","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"5497_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2021.109005","volume":"710","author":"D Rogacka","year":"2021","unstructured":"Rogacka D (2021) Insulin resistance in glomerular podocytes: potential mechanisms of induction. Arch Biochem Biophys 710:109005","journal-title":"Arch Biochem Biophys"},{"key":"5497_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2337\/dc20-1913","volume":"44","author":"H-T Cheng","year":"2021","unstructured":"Cheng H-T, Xu X, Lim PS, Hung K-Y (2021) Worldwide epidemiology of diabetes-related end-stage renal disease, 2000\u20132015. Diabetes Care 44:89\u201397","journal-title":"Diabetes Care"},{"key":"5497_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113025","volume":"150","author":"R Pathak","year":"2022","unstructured":"Pathak R, Sachan N, Chandra P (2022) Mechanistic approach towards diabetic neuropathy screening techniques and future challenges: a review. Biomed Pharmacother 150:113025","journal-title":"Biomed Pharmacother"},{"key":"5497_CR16","doi-asserted-by":"crossref","unstructured":"Ghosh D, Datta N, Banerjee D, Adhikary S, Banerjee S, De A (2024) Current Trends on Phytochemicals Toward Herbal Medicine Development. pp 1\u201326","DOI":"10.1007\/978-3-031-21973-3_16-1"},{"key":"5497_CR17","volume":"10","author":"S Bansal","year":"2024","unstructured":"Bansal S, Pratiksha K, Gaur R, Gupta S, Jadaun VP, Kumari V (2024) Comprehensive review on Schisandra chinesis. Pharmacol Res 10:100406","journal-title":"Pharmacol Res"},{"key":"5497_CR18","doi-asserted-by":"publisher","first-page":"6908","DOI":"10.1080\/21655979.2022.2026709","volume":"13","author":"X Min","year":"2022","unstructured":"Min X, Zhao L, Shi Y, Wang J, Lv H, Song X et al (2022) Gomisin J attenuates cerebral ischemia\/reperfusion injury by inducing anti-apoptotic, anti-inflammatory, and antioxidant effects in rats. Bioengineered 13:6908\u20136918","journal-title":"Bioengineered"},{"key":"5497_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113206","volume":"143","author":"R Murugan","year":"2024","unstructured":"Murugan R, Ashok K, Ramya Ranjan Nayak SP, Deivasigamani P, Almutairi MH, Almutairi BO et al (2024) COX-2 targeted therapy for diabetic foot ulcers using T7-enhanced CS-PVA membranes. Int Immunopharmacol 143:113206","journal-title":"Int Immunopharmacol"},{"key":"5497_CR20","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3892\/ijmm.2013.1263","volume":"31","author":"IS Hwang","year":"2013","unstructured":"Hwang IS, Kim JE, Lee YJ, Kwak MH, Choi YH, Kang BC et al (2013) Protective effects of Gomisin A isolated from Schisandra chinensis against CCl4-induced hepatic and renal injury. Int J Mol Med 31:888\u2013898","journal-title":"Int J Mol Med"},{"key":"5497_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22081298","volume":"22","author":"J Zhai","year":"2017","unstructured":"Zhai J, Zhang F, Gao S, Chen L, Feng G, Yin J et al (2017) Time- and NADPH-dependent inhibition on CYP3A by Gomisin A and the pharmacokinetic interactions between Gomisin A and cyclophosphamide in rats. Molecules 22:1298","journal-title":"Molecules"},{"key":"5497_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2024.114917","volume":"192","author":"SPR Nayak","year":"2024","unstructured":"Nayak SPR, Boopathi S, Chandrasekar M, Panda SP, Manikandan K, Chitra V et al (2024b) Indole-3-acetic acid exposure leads to cardiovascular inflammation and fibrosis in chronic kidney disease rat model. Food Chem Toxicol 192:114917","journal-title":"Food Chem Toxicol"},{"key":"5497_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2024.116917","volume":"486","author":"SPR Nayak","year":"2024","unstructured":"Nayak SPR, Boopathi S, Chandrasekar M, Yamini B, Chitra V, Almutairi BO et al (2024c) Indole-3 acetic acid induced cardiac hypertrophy in Wistar albino rats. Toxicol Appl Pharmacol 486:116917","journal-title":"Toxicol Appl Pharmacol"},{"key":"5497_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2024.104479","volume":"109","author":"SPR Nayak","year":"2024","unstructured":"Nayak SPR, Boopathi S, Almutairi BO, Arokiyaraj S, Kathiravan MK, Arockiaraj J (2024a) Indole-3-acetic acid induced cardiogenesis impairment in in-vivo zebrafish via oxidative stress and downregulation of cardiac morphogenic factors. Environ Toxicol Pharmacol 109:104479","journal-title":"Environ Toxicol Pharmacol"},{"key":"5497_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175994","volume":"957","author":"SPR Nayak","year":"2023","unstructured":"Nayak SPR, Dhivya LS, R R, Almutairi BO, Arokiyaraj S, Kathiravan MK et al (2023) Furan based synthetic chalcone derivative functions against gut inflammation and oxidative stress demonstrated in in-vivo zebrafish model. Eur J Pharmacol 957:175994","journal-title":"Eur J Pharmacol"},{"key":"5497_CR26","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/13543784.2017.1325872","volume":"26","author":"J Egido","year":"2017","unstructured":"Egido J, Rojas-Rivera J, Mas S, Ruiz-Ortega M, Sanz AB, Gonzalez Parra E et al (2017) Atrasentan for the treatment of diabetic nephropathy. Expert Opin. Investig. Drugs 26:741\u2013750","journal-title":"Expert Opin. Investig. Drugs"},{"key":"5497_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/life13020539","volume":"13","author":"T Wu","year":"2023","unstructured":"Wu T, Ding L, Andoh V, Zhang J, Chen L (2023) The mechanism of hyperglycemia-induced renal cell injury in diabetic nephropathy disease: an update. Life 13:539","journal-title":"Life"},{"key":"5497_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1497449","volume":"2021","author":"N Samsu","year":"2021","unstructured":"Samsu N (2021) Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int 2021:1497449","journal-title":"Biomed Res Int"},{"key":"5497_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4330\/wjc.v4.i4.90","volume":"4","author":"Z Hegab","year":"2012","unstructured":"Hegab Z (2012) Role of advanced glycation end products in cardiovascular disease. World J Cardiol 4:90","journal-title":"World J Cardiol"},{"key":"5497_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00109-014-1146-1","volume":"92","author":"SP Gray","year":"2014","unstructured":"Gray SP, Jandeleit-Dahm K (2014) The pathobiology of diabetic vascular complications\u2014cardiovascular and kidney disease. J Mol Med 92:441\u2013452","journal-title":"J Mol Med"},{"key":"5497_CR31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.intimp.2014.06.039","volume":"22","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Ren C, Lu G, Mu Z, Cui W, Gao H et al (2014) Anti-diabetic effect of mulberry leaf polysaccharide by inhibiting pancreatic islet cell apoptosis and ameliorating insulin secretory capacity in diabetic rats. Int Immunopharmacol 22:248\u2013257","journal-title":"Int Immunopharmacol"},{"key":"5497_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113069","volume":"142","author":"S-L Zhao","year":"2024","unstructured":"Zhao S-L, Liu D, Ding L, Liu G, Yao T, Wu L et al (2024) Schisandra chinensis lignans improve insulin resistance by targeting TLR4 and activating IRS-1\/PI3K\/AKT and NF-\u03baB signaling pathways. Int Immunopharmacol 142:113069","journal-title":"Int Immunopharmacol"},{"key":"5497_CR33","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/jcm9020472","volume":"9","author":"N Garcia-Fernandez","year":"2020","unstructured":"Garcia-Fernandez N, Jacobs-Cach\u00e1 C, Mora-Guti\u00e9rrez JM, Vergara A, Orbe J, Soler MJ (2020) Matrix metalloproteinases in diabetic kidney disease. J Clin Med 9:472","journal-title":"J Clin Med"},{"key":"5497_CR34","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1369\/0022155412465073","volume":"60","author":"SO Kolset","year":"2012","unstructured":"Kolset SO, Reinholt FP, Jenssen T (2012) Diabetic nephropathy and extracellular matrix. J Histochem Cytochem 60:976\u2013986","journal-title":"J Histochem Cytochem"},{"key":"5497_CR35","first-page":"120","volume":"6","author":"M Pourghasem","year":"2015","unstructured":"Pourghasem M, Shafi H, Babazadeh Z (2015) Histological changes of kidney in diabetic nephropathy. Casp J Intern Med 6:120\u2013127","journal-title":"Casp J Intern Med"},{"key":"5497_CR36","first-page":"70","volume":"11","author":"X Chen","year":"2019","unstructured":"Chen X, Liao D, Qin Z, Li X (2019) Synergistic interactions of Catalpol and stachyose in STZ-HFD induced diabetic mice: synergism in regulation of blood glucose, lipids, and hepatic and renal function. Chin Herb Med 11:70\u201377","journal-title":"Chin Herb Med"},{"key":"5497_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162131","volume":"11","author":"SJ Glastras","year":"2016","unstructured":"Glastras SJ, Chen H, Teh R, McGrath RT, Chen J, Pollock CA et al (2016) Mouse models of diabetes, obesity and related kidney disease. PLoS One 11:e0162131","journal-title":"PLoS One"},{"key":"5497_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115893","volume":"303","author":"T Wang","year":"2023","unstructured":"Wang T, Huang X, Zhai K, Yu J, Li J, Duan H et al (2023) Integrating metabolomics and network pharmacology to investigate Panax japonicus prevents kidney injury in HFD\/STZ-induced diabetic mice. J Ethnopharmacol 303:115893","journal-title":"J Ethnopharmacol"},{"key":"5497_CR39","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.2147\/DDDT.S89876","volume":"9","author":"Y Yu","year":"2015","unstructured":"Yu Y, Lai Q, Wei J, Mahmoodurrahman M, Zhang C, Quan S et al (2015) Pharmacokinetic and nephroprotective benefits of using schisandra chinensis extracts in a cyclosporine A-based immune-suppressive regime. Drug Des Devel Ther 9:4997","journal-title":"Drug Des Devel Ther"},{"key":"5497_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2025.109887","author":"SPR Nayak","year":"2025","unstructured":"Nayak SPR, Das A, Ramamurthy K, Pasupuleti M, Rajagopal R, Arockiaraj J (2025) Exposure to bisphenol A and sodium nitrate found in processed meat induces endocrine disruption and dyslipidemia through PI3K\/AKT\/SREBP pathway in zebrafish larvae. J Nutr Biochem. https:\/\/doi.org\/10.1016\/j.jnutbio.2025.109887","journal-title":"J Nutr Biochem"},{"key":"5497_CR41","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2021.05.025","volume":"171","author":"X-Q Wu","year":"2021","unstructured":"Wu X-Q, Zhang D-D, Wang Y-N, Tan Y-Q, Yu X-Y, Zhao Y-Y (2021) AGE\/RAGE in diabetic kidney disease and ageing kidney. Free Radic Biol Med 171:260\u2013271","journal-title":"Free Radic Biol Med"},{"key":"5497_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cells11081312","volume":"11","author":"A Twarda-Clapa","year":"2022","unstructured":"Twarda-Clapa A, Olczak A, Bia\u0142kowska AM, Kozio\u0142kiewicz M (2022) Advanced glycation End-Products (AGEs): formation, chemistry, classification, receptors, and diseases related to ages. Cells 11:1312","journal-title":"Cells"},{"key":"5497_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-2005-861360","volume":"37","author":"LJ Jensen","year":"2005","unstructured":"Jensen LJ, \u00d8stergaard J, Flyvbjerg A (2005) AGE-RAGE and AGE cross-link interaction: important players in the pathogenesis of diabetic kidney disease. Horm Metab Res 37:26\u201334","journal-title":"Horm Metab Res"},{"key":"5497_CR44","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/antiox13040455","volume":"13","author":"N Wang","year":"2024","unstructured":"Wang N, Zhang C (2024) Oxidative stress: a culprit in the progression of diabetic kidney disease. Antioxidants 13:455","journal-title":"Antioxidants"},{"key":"5497_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1047184","author":"Y Fang","year":"2023","unstructured":"Fang Y, Zhang Y, Jia C, Ren C, Zhao X, Zhang X (2023) Niaoduqing alleviates podocyte injury in high glucose model via regulating multiple targets and AGE\/RAGE pathway: network pharmacology and experimental validation. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1047184","journal-title":"Front Pharmacol"},{"key":"5497_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.498758","author":"F Heydarpour","year":"2020","unstructured":"Heydarpour F, Sajadimajd S, Mirzarazi E, Haratipour P, Joshi T, Farzaei MH et al (2020) Involvement of TGF-\u03b2 and autophagy pathways in pathogenesis of diabetes: a comprehensive review on biological and pharmacological insights. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.498758","journal-title":"Front Pharmacol"},{"key":"5497_CR47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.semnephrol.2007.02.009","volume":"27","author":"EP B\u00f6ttinger","year":"2007","unstructured":"B\u00f6ttinger EP (2007) TGF-\u03b2 in renal injury and disease. Semin Nephrol 27:309\u2013320","journal-title":"Semin Nephrol"},{"key":"5497_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cytogfr.2005.09.005","volume":"17","author":"E GAGLIARDINI","year":"2006","unstructured":"GAGLIARDINI E, BENIGNI A (2006) Role of anti-TGF-\u03b2 antibodies in the treatment of renal injury. Cytokine Growth Factor Rev 17:89\u201396","journal-title":"Cytokine Growth Factor Rev"},{"key":"5497_CR49","first-page":"131","volume":"22","author":"CE Hills","year":"2011","unstructured":"Hills CE, Squires PE (2011) The role of TGF-\u03b2 and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev 22:131","journal-title":"Cytokine Growth Factor Rev"},{"key":"5497_CR50","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000450","volume":"134","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt B, Aguilar D, Deswal A, Dunbar SB, Francis GS, Horwich T et al (2016) Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association. Circulation 134:23","journal-title":"Circulation"},{"key":"5497_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.695792","volume":"8","author":"T Salvatore","year":"2021","unstructured":"Salvatore T, Pafundi PC, Galiero R, Albanese G, Martino A, Di Caturano A et al (2021) The diabetic cardiomyopathy: the contributing pathophysiological mechanisms. Front Med 8:695792","journal-title":"Front Med"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05497-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05497-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05497-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:02:28Z","timestamp":1775642548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05497-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["5497"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05497-y","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures were approved by the Institutional Animal Ethics Committee (No. IAEC\/315\/2023).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors provided consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"During the writing of this manuscript, the authors used QuillBot and Grammarly to improve its readability and grammar. After using the tool, the authors reviewed and edited the content as needed and took full responsibility for the publication of the content.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure use of AI-assisted technologies"}}]}}